Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound.
The study objective was to gain insight into ultrasound-induced, sub-lytic cell surface modifications. Two primary hypotheses were tested by flow cytometric methods; viz., sonication will: 1. remove all or part of a specific cell surface marker in lymphocytes surviving insonation, and 2. induce transient pores in the cell membranes of some surviving cells. RPMI 1788 human lymphocytes were exposed in vitro to 1-MHz, continuous-wave ultrasound (approximately 8 W/cm2 ISP) for 30 s, which lysed approximately 50% of the cells. Insonation: 1. altered cell morphology, increasing the population of cells of reduced size but high structure (designated as population R2), many of which were nonviable, and diminishing the population of cells of large size and high structure (designated as population R1), most of which were viable, 2. diminished the fluorescence signal from the pan B lymphocyte marker CD19 in populations R1 and R2 to equivalent extents, and 3. increased by approximately 7-fold the number of transiently permeabilized cells in R1, as evidenced by simultaneous uptake of propidium iodide and fluorescein diacetate. The results indicate that ultrasound-induced CD19 removal from R1 cells can occur without accompanying gross membrane loss. The cell morphology/mortality shifts indicate that the ultrasound-induced morphological change is associated with lethal membrane poration, suggesting that the diminished CD19 fluorescence signal from insonated R2 cells arises partly by simultaneous loss of membrane fragments, CD19 and cytoplasm.
Brayman
A A
AA
Department of Obstetrics and Gynecology, School of Medicine and Dentistry, University of Rochester, NY 14642, USA. andrew_brayman@urmc.rochester.edu
Coppage
M L
ML
Vaidya
S
S
Miller
M W
MW
D018941:Antigens, CD19; D001402:B-Lymphocytes / Q000737:chemistry / Q000648:ultrastructure; D002460:Cell Line; D002470:Cell Survival; D006801:Humans; D016062:Porosity; D014465:Ultrasonics
D018941:Antigens, CD19